Literature DB >> 9176100

Proliferation and apoptosis of follicular lymphocytes: relationship to follicular dendritic cell-associated clusters.

H Orui1, M Yamakawa, Y Imai.   

Abstract

Experiments were designed to determine the in vivo cell-cycle phase of lymphocytes in secondary lymphoid follicles, and whether B-cell proliferation and apoptosis occur within follicular dendritic cell (FDC)-associated clusters. Using frozen serial sections of human tonsils, lymphoid follicles were stained to reveal histone H3 mRNA, as an S-phase marker, using in situ hybridization, and stained immunohistochemically with antibodies against cyclin E as a late G1 phase marker, cyclin B1 and p34cdc2 as S-G2-M phase markers, and Ki-67 as a marker of cycling cells. Each LF was divided into five zones: mantle zone, outer zone, apical light zone, basal light zone and dark zone, with the help of haematoxylin and eosin staining, and a CD23 immunostain. The rate of occurrence of positively labelled cells was calculated by dividing the number of positive cells by the number of all cells in each zone. The cells that were positive for cyclin E, histone H3 mRNA, cyclin B1, p34cdc2, and Ki-67 were found most frequently in the dark zone (54.5 +/- 6.6%, 22.0 +/- 5.7%, 36.7 +/- 14.5%, 40.0 +/- 10.2%, and 59.0 +/- 13.4%, respectively), followed by the outer zone (52.7 +/- 7.8%, 14.9 +/- 4.1%, 22.9 +/- 9.7%, 24.9 +/- 7.9%, and 44.6 +/- 12.3%, respectively), showing that both the outer zone and the dark zone contain many proliferating lymphocytes. Furthermore, FDC-associated clusters and free lymphocytes were obtained from enucleated germinal centres, using enzymatic digestion. The rates of occurrence of cells that were positive for cyclin B1 and Ki-67 within the clusters (7.2 +/- 1.9% and 37.9 +/- 10.5% respectively) were significantly lower than those of free lymphocytes outside the clusters (22.2 +/- 4.0% and 62.8 +/- 14.0%, respectively). The rates of occurrence of apoptotic bodies and cells within the clusters, as detected by in situ tailing or in situ nick translation (0.2 +/- 0.4% and 0.4 +/- 0.4%, respectively) were significantly lower than those outside the clusters (1.1 +/- 0.3, 1.6 +/- 0.5%, respectively). These results suggest that FDC-associated clusters are not the site of proliferation, and that they rarely contain apoptotic bodies and cells of B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176100      PMCID: PMC1456688          DOI: 10.1046/j.1365-2567.1997.00203.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  20 in total

1.  A rapid method to determine proliferation patterns of normal and malignant tissues by H3 mRNA in situ hybridization.

Authors:  M Y Chou; A L Chang; J McBride; B Donoff; G T Gallagher; D T Wong
Journal:  Am J Pathol       Date:  1990-04       Impact factor: 4.307

2.  Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67.

Authors:  J Gerdes; H Lemke; H Baisch; H H Wacker; U Schwab; H Stein
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

Review 3.  Immunohistochemistry with enzyme labeled antibodies: a brief review.

Authors:  A G Farr; P K Nakane
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

4.  Innunocytological studies on the constituent cells of the secondary nodules in human tonsils.

Authors:  R Tsunoda; Y Yaginuma; M Kojima
Journal:  Acta Pathol Jpn       Date:  1980-01

5.  Death of germinal center B cells without DNA fragmentation.

Authors:  M Nakamura; H Yagi; S Kayaba; T Ishii; T Gotoh; S Ohtsu; T Itoh
Journal:  Eur J Immunol       Date:  1996-06       Impact factor: 5.532

6.  Detection of transforming growth factor-alpha messenger RNA in normal and chemically transformed hamster oral epithelium by in situ hybridization.

Authors:  L C Chang; M Y Chou; P Chow; K Matossian; J McBride; C A Tao; G T Gallagher; D T Wong
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

7.  Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.

Authors:  Y J Liu; D Y Mason; G D Johnson; S Abbot; C D Gregory; D L Hardie; J Gordon; I C MacLennan
Journal:  Eur J Immunol       Date:  1991-08       Impact factor: 5.532

8.  Bromodeoxyuridine in tumors and chromosomes detected with a monoclonal antibody.

Authors:  G Morstyn; S M Hsu; T Kinsella; H Gratzner; A Russo; J B Mitchell
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  CD23: a multi-functional receptor/lymphokine?

Authors:  J Gordon; L Flores-Romo; J A Cairns; M J Millsum; P J Lane; G D Johnson; I C MacLennan
Journal:  Immunol Today       Date:  1989-05

10.  Follicular dendritic cells in suspension: identification, enrichment, and initial characterization indicating immune complex trapping and lack of adherence and phagocytic activity.

Authors:  C T Schnizlein; M H Kosco; A K Szakal; J G Tew
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  4 in total

1.  Differential expression of Ca(2+)-binding proteins on follicular dendritic cells in non-neoplastic and neoplastic lymphoid follicles.

Authors:  T Tsunoda; M Yamakawa; T Takahashi
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

2.  Local cell proliferation in rheumatoid synovial tissue: analysis by cyclin expression.

Authors:  Chikako Takahashi Tohyama; Mitsunori Yamakawa; Akira Murasawa; Kiyoshi Nakazono; Hajime Ishikawa
Journal:  Clin Rheumatol       Date:  2006-03-02       Impact factor: 2.980

3.  Expression of glucocorticoid receptors in non-neoplastic lymphoid follicles and B cell type malignant lymphomas.

Authors:  S-I Okazaki; M Yamakawa; K Maeda; N Ohta; M Aoyagi
Journal:  J Clin Pathol       Date:  2006-02-06       Impact factor: 3.411

4.  Localization of collagen modifying enzymes on fibroblastic reticular cells and follicular dendritic cells in non-neoplastic and neoplastic lymphoid tissues.

Authors:  Rintaro Ohe; Naing Ye Aung; Hongxue Meng; Takanobu Kabasawa; Aya Suto; Nobuyuki Tamazawa; Suran Yang; Tomoya Kato; Mitsunori Yamakawa
Journal:  Leuk Lymphoma       Date:  2015-12-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.